MARIETTA, Ga., Feb. 26, 2014 /PRNewswire/ -- MiMedx Group, Inc. /quotes/zigman/15761510/delayed/quotes/nls/mdxg MDXG +0.14% , an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its results for the year ended December 31, 2013.
Help employers find you! Check out all the jobs and post your resume.
